Aquaculture research continues progressing with the Targetfish Project

Bionaturis Group coordinator for Targetfish Project, PhD Ana de las Heras, has recently attended the annual meeting of this European Consortium, devoted to develop and provide the industry with new solutions for the most common diseases in European aquaculture. During the event, held in Athens, Bionaturis has explained the progresses in its developments  led to some of the major aquaculture species raised in Europe.

November 12th, 2015|Blog english|Comments Off|

Bionaturis Group takes part in the ‘Forum for the Public-Private Collaboration in Animal Health for Aquaculture”

Dr. Ana de las Heras, Project Manager at Bionaturis Group, attended the “Forum for the Public-Private Collaboration in Animal Health for Aquaculture”, that gathered more than 60 experts of the sector in Madrid. The workshop was organized by the Spanish Technology Platform for Animal Health, Vet+i,  and the Spanish Technology for Fishing and Aquaculture (PTEPA).

The promotion and the strengthening to approach public and private research institutions, technological centers and companies of the sector was the main objective of the event, that created a collaboration framework that has contributed to the networking  and the exchange of information to develop R&D activities.

The meeting showcased details of the Multiannual Strategic Programme for Spanish Aquaculture 2014-2010, as well as the current availability of medicines for the industry and the projects of several companies and research centers. As a novelty in this workshop, they celebrated up to 24 meetings B2B (Business to Business) between attendees.

This forum pursues one of the goals of the ‘Strategic Plan 2020’: contributing to the development of innovative medicines, promoting R&D devoted to the requirements and the new opportunities in the market of animal health. Aquaculture is one of the fields of activity of Bionaturis Group, having in development several products for unmet needs and taking part actively in the European Consortium Targetfish, among other things.

December 2nd, 2014|Blog english, congress|Comments Off|

Ana de las Heras: “The first year of Targetfish has been very satisfying”

Ph.D. Ana de las Heras is coordinating the participation of Bionaturis in Targetfish, the European consortium that is seeking solutions to the most common diseases in aquaculture. The balance after this first year is very positive.

-The research on health for aquaculture is one of the business activities in Bionaturis, what are the main milestones and where does the research head for? What are the next challenges?

Our goal is to offer innovative solutions for the prevention and control of diseases in aquaculture. We are focused on working in different and very important diseases for aquaculture, which, besides, will be useful as model for other ones. We expect to obtain soon the first results of testing new orally formulations in target species.

-In this way, Bionaturis is taking part in the European project Targetfish, that has just turned a year. What´s been the balance so far?

The first year has been very satisfying. Targetfish is a large consortium where most of the main European research groups that are working in immunology, fish pathology and aquaculture are taking part. All our effort is driven to obtain tangible solutions to the main diseases that are affecting European aquaculture. The consortium is very well-headed and there is a great commitment to achieve the set outcomes.

-Why is the research of health in aquaculture so important?

The world population is increasing and needs a first-class protein source. Aquaculture is essential to imbalance and satisfy the growing demand of aquatic products. Nowadays, aquaculture contributes nearly 50% of fish supply for human intake, and it is expected that in 2015 aquaculture will overtake the commercial fishing as main sources of fish protein. The increasing global demand of fish and shellfish, along with the limited capacity of […]

March 10th, 2014|Press english|0 Comments|

Two out of every three fish dishes will come from aquaculture in 2030

Aquaculture production is currently growing and will continue to do so in the coming years due to a substantial increase in demand. “According to the report ‘ fishing up to 2030: prospects for fishing and aquaculture”, released by the World Bank, the United Nations Organization for food and Agriculture (FAO) and the International Research Institute on food policies (IFPRI), two out of every three fish dishes in 2030 will come from aquaculture. In that year, It´s expected Asia – including Southeast Asia, China and Japan – to represent 70% of the global consumption of fish.

According to the study, both fishing and aquaculture are two important sources of employment and resources for developing countries. However, the diseases affecting aquaculture crop species are one of the main challenges and threats of the sector. To overcome that, Bionaturis works in preventive solutions such as oral vaccines intended to fight the most devastating salmon diseases. The company is also integrated in the European Targetfish project, dedicated to the research and development of preventive solutions for aquaculture, involving 30 partners from 13 different countries.

For further information about the aquaculture report, click here

Bionaturis will take part on a round table about Andalusian aquaculture R&D

Ana de las Heras, PhD in Veterinarian Sciences and scientist at Bionaturis, will take part on the conference called ‘R&D, an opportunity for the development of aquaculture in Andalusia’ on October 24th , organized by Ifapa (El Toruño Center) and the CAMPUS DE EXCELENCIA INTERNACIONAL DEL MAR” (CEIMAR) of Cadiz University (UCA).

Ana de las Heras will participate in the round table at 14.00 hours along with members of the companies Cupimar and Culmansur.

Check the full program and inscriptions here

October 18th, 2013|congress|0 Comments|

Bionaturis shed light on the oral vaccines for fish farming in Chile

The Andean country was affected in 2007 by one of the worst crises in the sector by ISA virus, causing a significant damage to its economic potential. Today, aquaculture companies have adopted new measures and still looking for cost-effective preventive solutions. In this sense, the International Workshop on “Immunology, diagnostic and therapies against infectious agents in the salmon industry” took place in Puerto Varas (21-22 march).
Renowned international experts have focused their attention on the major pathogens affecting the farmed fish: such as ISA virus (and more recently, Caligus pathogens). The assistants have agreed to step up cooperation in the key areas against infectious agents in Chile’s salmon farming industry, which today produces 840.000 tons.
Bionaturis, represented by Ph.D. Ana de las Heras has much to contribute to this endeavor, being an international reference on oral vaccines to be used in fish farming. The company shared their exclusive patented system, Flylife that was applauded by the experts. Bionaturis, with their proprietary formulations of oral-administrated vaccines, has proven to be ready to tackle effectively the challenges of this industry and to offer real solutions to the producers.

BIONATURIS will deliver a speech on oral vaccines for aquaculture in Chile

As an international reference on oral vaccines to be used in fish farmings, Bionaturis has been invited by Austral University of Chile and FONDEF to give an oral communication within the workshop titled “Diagnostic, Immunology and Therapies against infectious diseases affecting the salmon industry”. The workshop will be held between 21-22 March at Puerto Varas (Chile). Bionaturis expert in this field, Dra Ana de las Heras, will talk about the results and solutions on oral-administered vaccines the public-owned company is working on and how they could be applied to the salmon industry. Along Dra De las Heras, key industry leaders of the Chilean salmon sector will take part on this event.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.